Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Abstracts: AACR Special Conference: Targeting the PI3K-mTOR Network in Cancer; September 14-17, 2014; Philadelphia, PA

Clinical Data with PI3K and mTOR Inhibitors

      • Clinical Data with PI3K and mTOR Inhibitors: Oral Presentations - Invited Abstracts
      • Clinical Data with PI3K and mTOR Inhibitors: Poster Presentations - Proffered Abstracts

Downstream Effectors Underlying Cancer Progression

      • Downstream Effectors Underlying Cancer Progression: Oral Presentations - Invited Abstracts
      • Downstream Effectors Underlying Cancer Progression: Poster Presentations - Proffered Abstracts

Molecular Regulation of the PI3K-mTOR Network

      • Molecular Regulation of the PI3K-mTOR Network: Oral Presentations - Invited Abstracts
      • Molecular Regulation of the PI3K-mTOR Network: Oral Presentations - Proffered Abstracts
      • Molecular Regulation of the PI3K-mTOR Network: Poster Presentations - Proffered Abstracts

Opening Plenary Session

      • Keynote Talk: Oral Presentations - Invited Abstracts

PI3K-mTOR Activation in Human Cancer

      • PI3K-mTOR Activation in Human Cancer: Oral Presentations - Invited Abstracts
      • PI3K-mTOR Activation in Human Cancer: Poster Presentations - Proffered Abstracts

Preclinical and Clinical Studies in Breast Cancer

      • Preclinical and Clinical Studies in Breast Cancer: Oral Presentations - Invited Abstracts
      • Preclinical and Clinical Studies in Breast Cancer: Poster Presentations - Proffered Abstracts

Preclinical Models of PI3K-driven Cancers

      • Preclinical Models of PI3K-driven Cancers: Oral Presentations - Invited Abstracts
      • Preclinical Models of PI3K-driven Cancers: Poster Presentations - Proffered Abstracts

Resistance Mechanisms

      • Resistance Mechanisms: Oral Presentations - Invited Abstracts
      • Resistance Mechanisms: Oral Presentations - Proffered Abstracts
      • Resistance Mechanisms: Poster Presentations - Proffered Abstracts

The PI3K-mTOR Network in Hematopoetic Cancers

      • The PI3K-mTOR Network in Hematopoetic Cancers: Oral Presentations - Invited Abstracts
      • The PI3K-mTOR Network in Hematopoetic Cancers: Poster Presentations - Proffered Abstracts

Other Topics

      • Other Topics: Poster Presentations - Proffered Abstracts
Back to top
PreviousNext
Molecular Cancer Therapeutics: 14 (7 Supplement)
July 2015
Volume 14, Issue 7 Supplement
  • Table of Contents

Sign up for alerts

Jump to

  • Clinical Data with PI3K and mTOR Inhibitors
  • Downstream Effectors Underlying Cancer Progression
  • Molecular Regulation of the PI3K-mTOR Network
  • Opening Plenary Session
  • PI3K-mTOR Activation in Human Cancer
  • Preclinical and Clinical Studies in Breast Cancer
  • Preclinical Models of PI3K-driven Cancers
  • Resistance Mechanisms
  • The PI3K-mTOR Network in Hematopoetic Cancers
  • Other Topics
Advertisement
  • Most Cited
  • Most Read
Loading
  • CD137 Agonist mAb with Reduced Liver Toxicity
  • Truncated BRCA2 Contributes to PARPi Resistance
  • ERPAS to Predict Response to Endocrine Therapy
  • CDK8/19 Inhibitors Enhance NK-Cell–Mediated Cancer Therapy
  • Sialoglycan mAb for Cancer Immunotherapy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement